Rapid multiplex immunohistochemistry for characterizing tumor-immune microenvironment

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Intratumoral immune profiles impact cancer prognosis and treatment efficacy.
• Personalized medicine relies on identifying predictive biomarkers.
• Multiplex immunohistochemistry (IHC) is a standard for tissue evaluation.

Purpose of the Study:

• To develop a rapid, quantitative multiplex IHC method for evaluating intratumoral immune profiles.
• To adapt a previously developed 14-marker multiplex IHC into a faster 6-marker assay.
• To enable clinically feasible assessment of the tumor-immune microenvironment.

Main Methods:

• Reduced marker labels from 14 to 6 based on prognostic relevance.
• Optimized staining protocols (temperature, chromogen, washing time) for speed.
• Validated the 6-marker rapid multiplex IHC against conventional methods in benign tonsil and head and neck cancer tissues.

Main Results:

• The 6 selected markers correlated significantly with the 14 markers for immune classification.
• The rapid 6-marker multiplex IHC assay was completed in under 6 hours.
• Significant correlations were observed in staining intensity, immune cell densities, ratios, and spatial profiles compared to conventional IHC.

Conclusions:

• The developed 6-marker rapid multiplex IHC method provides a quantitative assessment of the tumor-immune microenvironment.
• This technique can be performed on a clinically feasible time scale.
• It supports the advancement of tissue biomarker-guided therapeutic strategies for personalized cancer treatment.